The AP-2 family of transcription factors

Genome Biology

Volumn 6, Issue 13, 2005, Pages

  Eckert, Dawid ^a   Buhl, Sandra ^a   Weber, Susanne ^a   Jäger, Richard ^a   Schorle, Hubert ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2 ALPHA; TRANSCRIPTION FACTOR AP 2 BETA; TRANSCRIPTION FACTOR AP 2 DELTA; TRANSCRIPTION FACTOR AP 2 EPSILON; TRANSCRIPTION FACTOR AP 2 GAMMA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BREAST CARCINOMA; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; DIMERIZATION; DNA BINDING; ECTODERM; EMBRYO DEVELOPMENT; HUMAN; INVERTEBRATE; KIDNEY DEVELOPMENT; MOLECULAR EVOLUTION; NEURAL CREST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SEMINOMA; TRANSACTIVATION; VERTEBRATE; ANIMAL; CHEMISTRY; EVOLUTION; METABOLISM; MULTIGENE FAMILY; PHYLOGENY; PROTEIN BINDING;

ANIMALIA; ANURA; HEXAPODA; INVERTEBRATA; NEMATODA; VERTEBRATA;

ANIMALS; EVOLUTION; HUMANS; MULTIGENE FAMILY; PHYLOGENY; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-2;

EID: 33746234890     PISSN: 1474760X     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2005-6-13-246     Document Type: Review

References (82)

1. Hilger-Eversheim K, Moser M, Schorle H, Buettner R: Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 2000, 260:1-12.
2. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD: Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 2001, 276:40755-40760.
3. Wang HV, Vaupel K, Buettner R, Bosserhoff AK, Moser M: Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev Dyn 2004, 231:128-135.
4. Feng W, Williams T: Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb. Mol Cell Neurosci 2003, 24:460-475.
5. IMCB - Fugu Genome Project [http://www.fugu-sg.org/]
6. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R: Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 1991, 5:105-119.
7. Snape AM, Winning RS, Sargent TD: Transcription factor AP-2 is tissue-specific in Xenopus and is closely related or identical to keratin transcription factor I (KTF-I). Development 1991, 113:283-293.
8. Meulemans D, Bronner-Fraser M: Amphioxus and lamprey AP-2 genes: implications for neural crest evolution and migration patterns. Development 2002, 129:4953-4962.
9. Williams T, Tjian R: Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 1991, 5:670-682.
10. Williams T, Tjian R: Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science 1991, 251:1067-1071.
11. Mohibullah N, Donner A, Ippolito JA, Williams T: SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex. Nucleic Acids Res 1999, 27:2760-2769.
12. Mitchell PJ, Wang C, Tjian R: Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 1987, 50:847-861.
13. Duan C, Clemmons DR: Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem 1995, 270:24844-24851.
14. Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M: Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J 1995, 14:1508-1519.
15. Newman SP, Bates NP, Vernimmen D, Parker MG, Hurst HC: Cofactor competition between the ligand-bound oestrogen receptor and an intron I enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene 2000, 19:490-497.
16. Li Q, Dashwood RH: Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells. J Biol Chem 2004, 279:45669-45675.
17. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM: Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 2004, 64:8256-8261.
18. Mazina OM, Phillips MA, Williams T, Vines CA, Cherr GN, Rice RH: Redistribution of transcription factor AP-2alpha in differentiating cultured human epidermal cells. J Invest Dermatol 2001, 117:864-870.
19. Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, Eskelinen M, Kosma VM: Expression of HER2 and its association with AP-2 in breast cancer. Eur J Cancer 2004, 40:1485-1495.
20. Li M, Wang Y, Hung MC, Kanman P: Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. Int J Cancer 2005. doi:10.1002/ijc.21426.
21. Nyormoi O, Wang Z, Doan D, Ruiz M, McConkey D, Bar-Eli M: Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells. Mol Cell Biol 2001, 21:4856-4867.
22. Garcia MA, Campillos M, Marina A, Valdivieso F, Vazquez J: Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation. FEBS Lett 1999, 444:27-31.
23. Park K, Kim KH: The site of cAMP action in the insulin induction of gene expression of acetyl-CoA carboxylase, is AP-2. J Biol Chem 1993, 268:17811-17819.
24. Zhong L, Wang Y, Kannan P, Tainsky MA: Functional characterization of the interacting domains of the positive coactivator PC4 with the transcription factor AP-2alpha. Gene 2003, 320:155-164.
25. Grether-Beck S, Felsner I, Brenden H, Krutmarm J: Mitochondrial cytochrome c release mediates ceramide-induced activator protein 2 activation and gene expression in keratinocytes. J Biol Chem 2003, 278:47498-47507.
26. Huang Y, Domann FE: Redox modulation of AP-2 DNA binding activity in vitro. Biochem Biophys Res Commun 1998, 249:307-312.
27. Bauer R, McGuffin ME, Mattox W, Tainsky MA: Cloning and characterization of the Drosophila homologue of the AP-2 transcription factor. Oncogene 1998, 17:1911-1922.
28. Monge I, Mitchell PJ: DAP-2, the Drosophilo homolog of transcription factor AP-2. Mech Dev 1998, 76:191-195.
29. Kerber B, Monge I, Mueller M, Mitchell PJ, Cohen SM: The AP-2 transcription factor is required for joint formation and cell survival in Drosophilo leg development. Development 2001, 128:1231-1238.
30. Monge I, Krishnamurthy R, Sims D, Hirth F, Spengler M, Kammermeier L, Reichert H, Mitchell PJ: Drosophila transcription factor AP-2 in proboscis, leg and brain central complex development. Development 2001, 128:1239-1252.
31. Luo T, Matsuo-Takasaki M, Thomas ML, Weeks DL, Sargent TD: Transcription factor AP-2 is an essential and direct regulator of epidermal development in Xenopus. Dev Biol 2002, 245:136-144.
32. Winning RS, Shea LJ, Marcus SJ, Sargent TD: Developmental regulation of transcription factor AP-2 during Xenopus laevis embryogenesis. Nucleic Acids Res 1991, 19:3709-3714.
33. Luo T, Lee YH, Saint-Jeannet JP, Sargent TD: Induction of neural crest in Xenopus by transcription factor AP2alpha. Proc Natl Acad Sci USA 2003, 100:532-537.
34. Knight RD, Javidan Y, Zhang T, Nelson S, Schilling TF: AP2-dependent signals from the ectoderm regulate craniofacial development in the zebrafish embryo. Development 2005, 132:3127-3138.
35. Holzschuh J, Barrallo-Gimeno A, Ettl AK, Durr K, Knapik EW, Driever W: Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype. Development 2003, 130:5741-5754.
36. Knight RD, Nair S, Nelson SS, Afshar A, Javidan Y, Geisler R, Rauch GJ, Schilling TF: lockjaw encodes a zebrafish tfap2a required for early neural crest development. Development 2003, 130:5755-5768.
37. Barrallo-Gimeno A, Holzschuh J, Driever W, Knapik EW: Neural crest survival and differentiation in zebrafish depends on mont blanc/tfap2a gene function. Development 2004, 131:1463-1477.
38. Knight RD, Javidan Y, Nelson S, Zhang T, Schilling T: Skeletal and pigment cell defects in the lockjaw mutant reveal multiple roles for zebrafish tfap2a in neural crest development. Dev Dyn 2004, 229:87-98.
39. Zhao F, Lufkin T, Gelb BD: Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis. Gene Expr Patterns 2003, 3:213-217.
40. Moser M, Ruschoff J, Buettner R: Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. Dev Dyn 1997, 208:115-124.
41. Chazaud C, Oulad-Abdelghani M, Bouillet P, Decimo D, Chambon P, Dolle P: AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 1996, 54:83-94.
42. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ: Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 1996, 381:235-238.
43. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, Williams T: Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 1996, 381:238-241.
44. Moser M, Dahmen S, Kluge R, Grone H, Dahmen J, Kunz D, Schorle H, Buettner R: Terminal renal failure in mice lacking transcription factor AP-2 beta. Lab Invest 2003, 83:571-578.
45. Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R et al.: Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev 1997, 11:1938-1948.
46. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, Williams T: Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. Development 2002, 129:2733-2747.
47. Werling U, Schorle H: Transcription factor gene AP-2γ essential for early murine development. Mol Cell Biol 2002, 22:3149-3156.
48. OMIM - Online Mendelian Inheritance in Man [http://www.ncbi.nlm.nih.gov/ entreztquery.fcgi?db=OMIM]
49. Zhao F, Weismann CG, Satoda M, Pierpont ME, Sweeney E, Thompson EM, Gelb BD: Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet 2001, 69:695-703.
50. Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont ME, Gelb BD: Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 2000, 25:42-46.
51. Plisterer P, Ehlermann J, Hegen M, Schorle H: A subtractive gene expression screen suggests a role of transcription factor AP-2 alpha in control of proliferation and differentiation. J Biol Chem 2002, 277:6637-6644.
52. Zhang J, Brewer S, Huang J, Williams T: Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis. Dev Biol 2003, 256:127-145.
53. Jager R, Werling U, Rimpf S, Jacob A, Schorle H: Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model. Mol Cancer Res 2003, 1:921-929.
54. Pauls K, Jager R, Weber S, Wardelmann E, Koch A, Buttner R, Schorle H: Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors. Int J Cancer 2005, 115:470-477.
55. Jager R, Friedrichs N, Heim I, Buttner R, Schorle H: Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis. Breast Cancer Res Treat 2005, 90:273-280.
56. Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, Leffers H, Meyts ER: Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 2004, 10:8521-8530.
57. Hurst HC: Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res 2001, 3:395-398.
58. Beger M, Butz K, Denk C, Williams T, Hurst HC, Hoppe-Seyler F: Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J Mol Med 2001, 79:314-320.
59. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG, Williams T: Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 1998, 58:5466-5472.
60. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC: A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 1996, 13:1701-1707.
61. Nelson DK, Williams T: Frontonasal process-specific disruption of AP-2alpha results in postnatal micifacial hypoplasia, vascular anomalies, and nasal cavity defects. Dev Biol 2004, 267:72-92.
62. Brewer S, Feng W, Huang J, Sullivan S, Williams T: Wnt1-Cremediated deletion of AP-2alpha causes multiple neural crest-related defects. Dev Biol 2004, 267:135-152.
63. Werling U, Schorle H: Conditional inactivation of transcription factor AP-2gamma by using the Cre/IoxP recombination system. Genesis 2002, 32:127-129.
64. Luo T, Zhang Y, Khadka D, Rangaraian J, Cho KW, Sargent TD: Regulatory targets for transcription factor AP2 in Xenopus embryos. Dev Growth Differ 2005, 47:403-413.
65. Friedrichs N, Jager R, Paggen E, Rudlowski C, Merkelbach-Bruse S, Schorle H, Buettner R: Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer. Mod Pathol 2005, 18:431-438.
66. Hoei-Hansen CE, Nielsen JE, Almstrup K, Hansen MA, Skakkebaek NE, Raipert-DeMeyts E, Leffers H: Identification of genes differentially expressed in testes containing carcinoma in situ. Mol Hum Reprod 2004, 10:423-431.
67. Kumar S, Tamura K, Nei M: MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004, 5:150-163.
68. Swiss-Prot [http://us.expasy.org/sprot/]
69. Braganca J, Eloranta JJ, Bamforth SID, Ibbitt JC, Hurst HC, Bhattacharya S: Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem 2003, 278:16021-16029.
70. Braganca J, Swingler T, Marques FI, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S: Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2. J Biol Chem 2002, 277:8559-8565.
71. Wu F, Lee AS: CDP and AP-2 mediated repression mechanism of the replication-dependent hamster histone H3.2 promoter. J Cell Biochem 2002, 84:699-707.
72. Campillos M, Garcia MA, Valdivieso F, Vazquez J: Transcriptional activation by AP-2alpha is modulated by the oncogene DEK. Nucleic Acids Res 2003, 31:1571-1575.
73. Somasundaram K, Jayaraman G, Williams T, Moran E, Frisch S, Thimmapaya B: Repression of a matrix metalloprotease gene by EIA correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad Sci USA 1996, 93:3088-3093.
74. Kannan P, Yu Y, Wankhade S, Tainsky MA: PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 1999, 27:866-874.
75. Sivak JM, West-Mays JA, Yee A, Williams T, Fini ME: Transcription factors Pax6 and AP-2alpha interact to coordinate corneal epithelial repair by controlling expression of matrix metalloproteinase gelatinase B. Mol Cell Biol 2004, 24:245-257.
76. McPherson LA, Loktev AV, Weigel RJ: Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. J Biol Chem 2002, 277:45028-45033.
77. Wu F, Lee AS: Identification of AP-2 as an interactive target of Rb and a regulator of the GI/S control element of the hamster histone H3.2 promoter. Nucleic Acids Res 1998, 26:4837-4845.
78. Batsche E, Muchardt C, Behrens J, Hurst HC, Cremisi C: RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998, 18:3647-3658.
79. Pena P, Reutens AT, Albanese C, D'Amico M, Watanabe G, Donner A, Shu IW, Williams T, Pestell RG: Activator protein-2 mediates transcriptional activation of the CYPIIAI gene by interaction with Sp1 rather than binding to DNA. Mol Endocrinol 1999, 13:1402-1416.
80. Eloranta JJ, Hurst HC: Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J Biol Chem 2002, 277:30798-30804.
81. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH: A synergistic interaction of transcription factors AP2 and YB-1 regulates, gelatinase A enhancer-dependent transcription. J Biol Chem 1998, 273:32957-32965.
82. Wu F, Lee AS: YYI as a regulator of replication-dependent hamster histone H3.2 promoter and an interactive partner of AP-2. J Biol Chem 2001, 276:28-34.